Galapagos NV (NASDAQ:GLPG)
| 44.38 BATS BZX Real-Time Price As of 1:44pm ET |  -0.23 / -0.52%Today’s Change | 37.24 Today|||52-Week Range 72.11 | 0.00% Year-to-Date |
Latest GLPG News | Press Releases
No recent news for Galapagos NV.
Today’s Trading
| Previous close | 44.61 |
| Today’s open | 43.89 |
| Day’s range | 43.89 - 44.50 |
| Volume | 1,395 |
| Average volume (3 months) | 166,557 |
| Market cap | $3.0B |
Data as of 1:44pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | +57.70% |
| Earnings growth (this year) | +46.86% |
| Earnings growth (next 5 years) | +17.84% |
| Revenue growth (last year) | +5.16% |
| P/E ratio | 453.8 |
| Price/Sales | 6.30 |
| Price/Book | 1.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INSMInsmed Inc | +0.23 | +1.07% |
| ISEEIVERIC bio Inc | +0.88 | +4.00% |
| BHCValeant Pharmaceutic... | -0.05 | -0.59% |
| ACADACADIA Pharmaceutica... | -0.11 | -0.59% |
Data as of 2:04pm ET, 01/27/2023
Financials
| Next reporting date | February 24, 2023 |
| EPS forecast (this quarter) | -$0.65 |
| Annual revenue (last year) | $573.1M |
| Annual profit (last year) | -$148.2M |
| Net profit margin | -25.87% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Mechelen, Brussels Region |
Forecasts
